| 证券代码 | BFRA.O |
| 证券名称 | Biofrontera AG ADR |
| 证券类型 | 美国存托凭证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2018-02-14 |
| 首发价格(元) | 9.88 USD |
| 首发数量(股) | 1215000 |
| 首发募资额(元) | 12,004,200.00 USD |
| 首发主承销商 | The Benchmark Company, LLC |
| 货币单位 | EUR |
| 公司名称 | Biofrontera AG |
| 注册地址 | 德国 |
| 办公地址 | Hemmelrather Weg 201, Leverkusen, Germany |
| 成立日期 | 1997 |
| 董事会主席 | Ulrich Granzer |
| 公司属地 | Germany 德国 |
| 公司网址 | www.biofrontera.com |
| 电话 | +49 (214) 8-7600 |
| 传真 | - |
| 公司简介 | Biofrontera AG is an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. It conducts its own research and development and, in several regions, including the U.S., market and sell its own products. |